Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01GM112696 | lncRNAs and Anesthetic-Induced Developmental Neurotoxicity | 1 | 2022 |
| R01HG010372 | Integrated pathogenicity assessment of clinically actionable genetic variants | 1 | 2022 |
| R01HL061690 | Targeting GRK2 in the Heart | 1 | 2022 |
| R01HL063043 | Controlled and Uncontrollable Calcium release in heart | 1 | 2022 |
| R01HL106579 | Nucleolin Regulation of miRome by Shear Stress | 1 | 2022 |
| R01HL140074 | Genomic and Phenomic Architecture of Heart Failure | 1 | 2022 |
| R01HL141081 | The Role of Cardiomyogenic Lineage Commitment in Cardiac Mesenchymal Cell-Mediated Extracellular Vesicle Signaling and Cardiac Repair | 1 | 2022 |
| R01HL141345 | scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients | 1 | 2022 |
| R01HL142520 | Molecular Determinants of Regional Differences in Human Ventricular Repolarization and Remodeling | 1 | 2022 |
| R01HL143295 | Return of Genomic Results and Estimating Penetrance in Population-Based Cohorts | 1 | 2022 |
| R01HL144157 | Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenation | 1 | 2022 |
| R01HL146744 | Heart-platelet crosstalk: JNK, AF, and thrombogenesis | 1 | 2022 |
| R01HL146868 | Mechanisms of Cell-Based Heart Regeneration | 1 | 2022 |
| R01HL147263 | Molecular Regulation of cardiac adrenergic signaling | 1 | 2022 |
| R01HL147558 | Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF | 1 | 2022 |
| R01HL147570 | Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction | 1 | 2022 |
| R01HL148059 | A Multi-Omics Approach to Discover Metabolic Critical Quality Attributes for Cardiomyocyte Biomanufacturing | 1 | 2022 |
| R01HL149137 | Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals | 1 | 2022 |
| R01HL149159 | Metabolic Rhythm Alterations as a Cause for Obesity Cardiomyopathy | 1 | 2022 |
| R01HL149401 | Molecular Mechanisms of Dystrophic Cardiomyopathy | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=34